CD8A and COVID-19: Studies of acute and convalescent COVID-19 patients have observed that T cell responses are associated with reduced disease [37, 38], suggesting that SARS-CoV-2-specific CD4+ and CD8+ T cell responses contribute significantly to infection control and resolution.